| RS61734354 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS61734356 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS61734479 |
FBLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Macular degeneration, age-related |
| RS61734561 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS61734629 |
DNAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS61734891 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 37, Autosomal dominant nonsyndromic hearing loss 22 |
| RS61735002 |
PRSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS61735035 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61735272 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS61735299 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Junctional epidermolysis bullosa with pyloric atresia |
| RS61735331 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61735359 |
GH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Decreased response to growth hormone stimulation test, GH1-related disorder |
| RS61735388 |
SPDL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61735479 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1F |
| RS61735488 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS61735510 |
NUP214
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61735580 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS61735596 |
MASP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to MASP-2 deficiency, Immunodeficiency due to MASP-2 deficiency |
| RS61735621 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS61735622 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS61735631 |
JAK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammation, immune dysregulation |
| RS61735712 |
KCNC2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 103, Developmental and epileptic encephalopathy 103 |
| RS61735719 |
GPR39
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61735731 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Vesicoureteral reflux 8 |
| RS61735772 |
TMPRSS15
|
Health Risk |
Conflicting classifications of pathogenicity |
Enterokinase deficiency, Enterokinase deficiency |
| RS61735807 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS61735808 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS61735813 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS61735823 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS61735825 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS61735832 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS61735833 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS61735859 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, Familial thoracic aortic aneurysm and aortic dissection |
| RS61735983 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS61735984 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS61736002 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Meniere disease, Autosomal recessive nonsyndromic hearing loss 18B |
| RS61736057 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS61736168 |
MARVELD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 49, Autosomal recessive nonsyndromic hearing loss 49 |
| RS61736269 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS61736350 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61736380 |
PEX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder 6B |
| RS61736440 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblG, Neural tube defects |
| RS61736558 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS61736559 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS61736585 |
PACS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schuurs-Hoeijmakers syndrome, Inborn genetic diseases |
| RS61736587 |
STXBP2
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Autoinflammatory syndrome |
| RS61736595 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS61736656 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS61736659 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS61736710 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS61736727 |
VRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1A, Inborn genetic diseases |
| RS61736761 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61736773 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS617368 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61736827 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS61736886 |
EGFL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61736892 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS61736895 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS61736923 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency 2, MHC class I deficiency 2 |
| RS61736941 |
TXNRD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Glucocorticoid deficiency 5 |
| RS61736948 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS61736969 |
TBC1D4
|
Health Risk |
risk factor |
TYPE 2 DIABETES MELLITUS 5, SUSCEPTIBILITY TO |
| RS61737008 |
MMP13
|
Health Risk |
Pathogenic |
— |
| RS61737058 |
SVIL
|
Health Risk |
Conflicting classifications of pathogenicity |
SVIL-related disorder, SVIL-related disorder |
| RS61737080 |
ITGB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS61737098 |
PCK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Phosphoenolpyruvate carboxykinase deficiency, mitochondrial |
| RS61737172 |
RAD21
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS61737194 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHD7-related disorder |
| RS61737447 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, MYO5B-related disorder |
| RS61737507 |
FARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
FARSA-related disorder, Melanoma |
| RS61737684 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS61737688 |
MLPH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61737739 |
TNC
|
Health Risk |
Conflicting classifications of pathogenicity |
TNC-related disorder, TNC-related disorder |
| RS61737748 |
NEK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 6 with or without polydactyly, NEK1-related disorder |
| RS61737825 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Long QT syndrome 3 |
| RS61737942 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS61737991 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS61738009 |
CPA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 5, Global developmental delay |
| RS61738013 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS61738022 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS61738024 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS61738394 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, OCA2-related disorder |
| RS61738519 |
DSPP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61738521 |
TBX6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS61738625 |
ADA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of adenosine deaminase 2, Autoinflammatory syndrome |
| RS61738782 |
UTRN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739302 |
SSH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739388 |
MMAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria, cblB type |
| RS61739399 |
KNSTRN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739427 |
GNPTG
|
Health Risk |
Conflicting classifications of pathogenicity |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS61739459 |
MYO16
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739618 |
ZNF687
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF687-related disorder, ZNF687-related disorder |
| RS61739637 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, NPHP4-related disorder |
| RS61739694 |
RIPK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartsocas-Papas syndrome 1, RIPK4-related disorder |
| RS61739705 |
GABRR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739720 |
SLC6A11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61739895 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS61739911 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS61739928 |
ARHGEF28
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGEF28-related disorder, Meniere disease |
| RS61739965 |
COX6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease recessive intermediate D, Charcot-Marie-Tooth disease recessive intermediate D |